Skip to main content
. 2010 Apr 26;5(4):e10311. doi: 10.1371/journal.pone.0010311

Figure 1. Virological evolution in three patients with virological failure on Raltegravir-containing therapy.

Figure 1

Time of follow-up is expressed in months (M0 to M12). Baseline integrase polymorphisms appear at month 0. Additional selected mutations preceded by (+), or switches to different genotypic patterns, are indicated in the follow-up. Abbreviations: VL: Viral load (Plasma HIV-1 RNA); RAL: raltegravir; TDF: tenofovir diphospho fumarate; ETR: etravirine; DRV/r: darunavir boosted with ritonavir; ENF: enfuvirtide; FTC: emtricitabine.